Table 2.

Matrix of Pairwise Comparisons Among Different Surgical Methods for Efficacy and Safety (shown as mean difference and 95% confidence intervals), including proptosis (a), logMAR BCVA (b), and the rate of new-onset primary gaze diplopia (c). The groups are denoted as follows: A: fat removal orbital decompression, B: medial wall, C: lateral wall, D: balanced wall, E: infero-medial wall, F: three-wall

	F	D	E	C	B	A
SUCRA (%)	100	77.0	59.7	37.1	18.2	8.1
F	0	1.69(1.02, 2.37)	2.16(1.29 3.03)	2.70(1.90, 3.50)	3.16(2.19, 4.14)	3.47(2.37, 4.58)
D	-1.69(-2.37, -1.02)	0	0.46(-0.40, 1.33)	1.00(0.34, 1.67)	1.47(0.52, 2.42)	1.78(0.74, 2.82)
E	-2.16(-3.03, -1.29)	-0.46(-1.33, 0.40)	0	0.54(-0.44, 1.52)	1.01(0.08, 1.93)	1.32(0.22, 2.41)
C	-2.70(-3.50, -1.90)	-1.00(-1.67, -0.34)	-0.54(-1.52, 0.44)	0	0.46(-0.58, 1.51)	0.78(-0.38, 1.93)
B	-3.16(-4.14, -2.19)	-1.47(-2.42, -0.52)	-1.01(-1.93, -0.08)	-0.46(-1.51, 0.58)	0	0.31(-0.82, 1.44)
A	-3.47(-4.58, -2.37)	-1.78(-2.82, -0.74)	-1.32(-2.41, -0.22)	-0.78(-1.93, 0.38)	-0.31(-1.44, 0.82)	0
(a)
	E	F	B	D	C
SUCRA (%)	78.3	72.9	54.9	43.4	0.6
E	0	0.02(-0.14, 0.17)	0.06(-0.11, 0.23)	0.09(-0.12, 0.29)	0.25(0.06, 0.44)
F	-0.02(-0.17, 0.14)	0	0.04(-0.12, 0.20)	0.07(-0.07, 0.21)	0.24(0.10, 0.37)
B	-0.06(-0.23, 0.11)	-0.04(-0.20, 0.12)	0	0.03(-0.16, 0.21)	0.20(0.03, 0.36)
D	-0.09(-0.29, 0.12)	-0.07(-0.21, 0.07)	-0.03(-0.21, 0.16)	0	0.17(0.04, 0.30)
C	-0.25(-0.44, -0.06)	-0.24(-0.37, -0.10)	-0.20(-0.36, -0.03)	-0.17(-0.30, -0.04)	0
(b)
	C	D	F	E
SUCRA (%)	93.7	70.7	27.3	8.2
C	0	2.54(0.40,16.00)	9.67(1.15, 81.07)	18.51(1.52, 225.30)
D	0.39(0.06, 2.47)	0	3.80(1.05, 13.80)	7.28(1.15, 46.16)
F	0.10(0.01, 0.87)	0.26(0.07, 0.95)	0	1.91(0.36, 10.30)
(c)